Compounds > sulfadiazine, trimethoprim drug combination
Page last updated: 2024-08-24

sulfadiazine, trimethoprim drug combination and Acute Myelogenous Leukemia

sulfadiazine, trimethoprim drug combination has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Early, A; Hryniuk, W; Preisler, HD1

Other Studies

1 other study(ies) available for sulfadiazine, trimethoprim drug combination and Acute Myelogenous Leukemia

ArticleYear
Prevention of infection and bleeding in leukemic patients receiving intensive remission maintenance therapy.
    Medical and pediatric oncology, 1981, Volume: 9, Issue:5

    Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Bacterial Infections; Drug Combinations; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Sulfadiazine; Thrombocytopenia; Trimethoprim

1981